Loading...
Publication
T790M-EGFR mutation frequency in advanced NSCLC patients on progression from a previous TKI therapy: results from a Portuguese study
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 583.4 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Description
Keywords
Carcinoma do Pulmão de Células não Pequenas Resistencia a Medicamentos Antineoplásicos Receptor ErbB-2 Carcinoma, Non-Small-Cell Lung Drug Resistance, Neoplasm ErbB Receptors
Citation
Pulmonology . Sep-Oct 2021;27(5):472-473.